These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Risk factors of cardiovascular disease in GH-deficient adults with hypopituitarism: a preliminary report. Bohdanowicz-Pawlak A; Szymczak J; Bladowska J; Bednarek-Tupikowska G; Bidzińska B; Milewicz A Med Sci Monit; 2006 Feb; 12(2):CR75-80. PubMed ID: 16449951 [TBL] [Abstract][Full Text] [Related]
3. Effect of growth hormone (GH) on fasting and postprandial metabolism in GH deficiency. Trepp R; Stettler C; Diem P; Christ ER Exp Clin Endocrinol Diabetes; 2010 Oct; 118(9):596-601. PubMed ID: 20146168 [TBL] [Abstract][Full Text] [Related]
4. Abnormalities in bone mineral density distribution and bone scintigraphy in patients with childhood onset hypopituitarism. Kosowicz J; El Ali Z; Ziemnicka K; Sowinski J J Clin Densitom; 2007; 10(3):332-9. PubMed ID: 17470407 [TBL] [Abstract][Full Text] [Related]
5. Replacement therapy and cardiovascular diseases. Boschetti M; Goglia U; Teti C; Esposito D; Giusti M; Minuto F; Ferone D J Endocrinol Invest; 2008 Sep; 31(9 Suppl):85-90. PubMed ID: 19020394 [TBL] [Abstract][Full Text] [Related]
7. The GH-IGF-I axis and the cardiovascular system: clinical implications. Colao A Clin Endocrinol (Oxf); 2008 Sep; 69(3):347-58. PubMed ID: 18462260 [TBL] [Abstract][Full Text] [Related]
8. Growth hormone-induced increases in skeletal muscle mass alleviates the associated insulin resistance in short children born small for gestational age, but not with growth hormone deficiency. Martin DD; Schweizer R; Schönau E; Binder G; Ranke MB Horm Res; 2009; 72(1):38-45. PubMed ID: 19571558 [TBL] [Abstract][Full Text] [Related]
9. Effect of short-term therapy with recombinant human growth hormone (GH) on metabolic parameters and preclinical atherosclerotic markers in hypopituitary patients with growth hormone deficiency. Benedini S; Dalle Carbonare L; Albiger N; Scanarini M; Bilora F; Petrobelli F; Giannini S; Mantero F; Scaroni C Horm Metab Res; 2006 Jan; 38(1):16-21. PubMed ID: 16477535 [TBL] [Abstract][Full Text] [Related]
10. Growth hormone deficient patients after traumatic brain injury--baseline characteristics and benefits after growth hormone replacement--an analysis of the German KIMS database. Kreitschmann-Andermahr I; Poll EM; Reineke A; Gilsbach JM; Brabant G; Buchfelder M; Fassbender W; Faust M; Kann PH; Wallaschofski H Growth Horm IGF Res; 2008 Dec; 18(6):472-8. PubMed ID: 18829359 [TBL] [Abstract][Full Text] [Related]
11. Growth hormone deficiency, low levels of adiponectin, and unfavorable plasma lipid and lipoproteins. Lanes R; Soros A; Gunczler P; Paoli M; Carrillo E; Villaroel O; Palacios A J Pediatr; 2006 Sep; 149(3):324-9. PubMed ID: 16939741 [TBL] [Abstract][Full Text] [Related]
12. Muscle strength and power, maximum oxygen consumption, and body composition in middle-aged short-stature adults with childhood-onset growth hormone deficiency. Sartorio A; Agosti F; De Col A; Mazzilli G; Marazzi N; Busti C; Galli R; Lafortuna CL Arch Med Res; 2008 Jan; 39(1):78-83. PubMed ID: 18067999 [TBL] [Abstract][Full Text] [Related]
13. Beginning to end: cardiovascular implications of growth hormone (GH) deficiency and GH therapy. Colao A; Di Somma C; Savanelli MC; De Leo M; Lombardi G Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S41-8. PubMed ID: 16690338 [TBL] [Abstract][Full Text] [Related]
14. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients. Fideleff HL; Boquete HR; Stalldecker G; Giaccio AV; Sobrado PG Growth Horm IGF Res; 2008 Aug; 18(4):318-24. PubMed ID: 18289903 [TBL] [Abstract][Full Text] [Related]
15. Cardiac functional reserve is diminished in growth hormone-deficient adults. Moisey R; Orme S; Barker D; Lewis N; Sharp L; Clements RE; Goldspink DF; Tan LB Cardiovasc Ther; 2009; 27(1):34-41. PubMed ID: 19207478 [TBL] [Abstract][Full Text] [Related]
16. Abnormal prorenin processing in growth hormone deficiency. Gordon MS; Caston-Balderrama AL; Gordon MB Growth Horm IGF Res; 2005 Aug; 15(4):251-5. PubMed ID: 15967698 [TBL] [Abstract][Full Text] [Related]
18. Impact of 5 years of growth hormone replacement therapy on cardiovascular risk factors in growth hormone-deficient adults. Cenci MC; Conceição FL; Soares DV; Spina LD; Brasil RR; Lobo PM; Michmacher E; Vaisman M Metabolism; 2008 Jan; 57(1):121-9. PubMed ID: 18078869 [TBL] [Abstract][Full Text] [Related]
19. [The influence of long-term growth hormone replacement therapy on body composition, bone tissue and some metabolic parameters in adults with growth hormone deficiency]. Olsovská V; Siprová H; Beránek M; Soska V Vnitr Lek; 2005 Dec; 51(12):1356-64. PubMed ID: 16430102 [TBL] [Abstract][Full Text] [Related]
20. Diagnosis and growth hormone (GH) therapy in children with GH deficiency: experience in King Chulalongkorn Memorial Hospital, Thailand. Wacharasindhu S; Supornsilchai V; Aroonparkmongkol S; Srivuthana S J Med Assoc Thai; 2007 Oct; 90(10):2047-52. PubMed ID: 18041422 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]